Medico Remedies Limited

NSE MEDICO.NS

Medico Remedies Limited Free Cash Flow Per Share for the year ending March 31, 2024: USD 0.00

Medico Remedies Limited Free Cash Flow Per Share is USD 0.00 for the year ending March 31, 2024, a -87.20% change year over year. Free cash flow per share is the free cash flow generated per share. Indicates investment potential based on cash flow generation.

Medico Remedies Limited Free Cash Flow Per Share for the year ending March 31, 2023 was USD 0.00, a 732.59% change year over year.
Medico Remedies Limited Free Cash Flow Per Share for the year ending March 31, 2022 was USD -0.00, a -146.99% change year over year.
Medico Remedies Limited Free Cash Flow Per Share for the year ending March 31, 2021 was USD 0.00, a 120.57% change year over year.
Medico Remedies Limited Free Cash Flow Per Share for the year ending March 31, 2020 was USD -0.00, a -275.67% change year over year.

Key data

Date	Free Cash Flow Per Share	Return on Assets (ROA)	Return on Equity (ROE)	Return on Capital Employed (ROCE)

NSE: MEDICO.NS

Medico Remedies Limited

CEO	Mr. Haresh Kapurlal Mehta
IPO Date	May 26, 2022
Location	India
Headquarters	1105/1106, Hubtown Solaris
Employees	193
Sector	Healthcare
Industries Drugstores & Retail Pharmacies Clinical Trials Fertilizers Pharmaceuticals

Description

Medico Remedies Limited manufactures and sells allopathic pharmaceutical preparations in India. The company offers antibiotics and anti-infective drugs; beta-lactams, and penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, and anti-epileptics and antipsychotics products; antimalarial medicines; dry syrups; ointments and creams; anti-diabetics products; and syrups. It also exports its products to Kazakhstan, Kyrgyzstan, Botswana, Jamaica, and Niger. Medico Remedies Limited was incorporated in 1994 and is based in Mumbai, India.

Key trends

Past 5 years